MOESM1 of Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis

Additional file 1. Associated Data.The file included the data of the treatment of 175 NSCLC patients. The treatment group was divided into 2 subgroups(0 for pCT and 1 for POCRT).The gender, age, ECOG scoring ,tumor position, Vessel invasion, T stage, Operation modality, Pathology, pN stage, Chemotherapy cycles, Total number of MLNs and CTV dose were divided into different subgroups according to the details list in the Table 1. The OS was calculated from the date of diagnosis to the date of death, or the date of the last follow-up. The survival group was divided into 2 subgroups (0 for survival and 1 for death). (XLSX 35 kb)

附加文件1：关联数据集。本文件涵盖175例非小细胞肺癌（NSCLC）患者的治疗相关数据。治疗组划分为2个亚组，其中0代表pCT，1代表POCRT。性别、年龄、ECOG评分、肿瘤位置、血管侵犯情况、T分期、手术方式、病理分型、病理淋巴结（pN）分期、化疗周期数、区域淋巴结总数（MLNs）以及临床靶区（CTV）剂量，均按照表1中的明细列表进行分组。总生存期（OS）的计算周期为患者确诊日期至死亡日期，或末次随访日期。生存组分为2个亚组，0代表存活，1代表死亡。（XLSX格式，文件大小35 KB）